Epidemiological studies and early clinical data suggest that GLP-1 receptor agonists may reduce the risk of neurodegenerative diseases including Alzheimer disease, Parkinson disease, and other forms of dementia
The medication works primarily by activating GLP-1 receptors in the brain regions responsible for appetite control and satiety signaling
Eight weeks in on glutathione twice a week and the recovery curve is genuinely shorter. Naomi T
Sikiric P, Rucman R, Turkovic B, et al
Its reminiscent of how, a decade or so ago, we were utterly obsessed with whether or not a celebrity had had work done. This was before injectables like Botox and fillers went mainstream, thanks in large part to celebrities using them, resulting in a normalization were now likely to see with these weight loss drugs